Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.68 |
| ▸ | CA1 | P00915 | 3/20 | 0.68 |
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | CA9 | Q16790 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | CA7 | P43166 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MMP1 | P03956 | 2/20 | 0.55 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | MMP14 | P50281 | 1/20 | 0.55 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7368029 | 0.98 | CA12 (0.66) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4535363 | 0.96 | TSHR (0.64) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4537643 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4524560 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4530059 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4529708 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4533781 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4527703 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4533770 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4539506 | 0.95 | TSHR (0.62) | CA12CA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4404273-A | Process for the production of photographic color images by the silver dye bleach process | CIBA-GEIGY AG (CH) | 1983-09-13 | — | — | US | claimed |
| US-9707757-B2 | Photosensitive negative resin composition | CANON KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9707757-B2 | Photosensitive negative resin composition | CANON KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9268222-B2 | Photosensitive negative resin composition, fine structure, production process of fine structure and liquid ejection head | CANON KABUSHIKI KAISHA (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9268222-B2 | Photosensitive negative resin composition, fine structure, production process of fine structure and liquid ejection head | CANON KABUSHIKI KAISHA (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20150336892-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC (US) | 2015-11-26 | — | — | US | disclosed |
| US-9196864-B2 | Encapsulated structure of light-emitting device, encapsulating process thereof and display device comprising encapsulated structure | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2015-11-24 | — | — | US | disclosed |
| EP-2628050-B1 | PHOTOSENSITIVE NEGATIVE RESIN COMPOSITION | CANON KK (JP) | 2015-09-09 | — | — | EP | disclosed |
| US-8975003-B2 | Photosensitive negative resin composition | CANON KABUSHIKI KAISHA (JP) | 2015-03-10 | — | — | US | disclosed |
| US-8975003-B2 | Photosensitive negative resin composition | CANON KABUSHIKI KAISHA (JP) | 2015-03-10 | — | — | US | disclosed |
| US-7534554-B2 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20080233518-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND MANUFACTURING METHOD OF SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE WITH SUCH CHEMICALLY AMPLIFIED RESIST COMPOSITION | NEC ELECTRONICS CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-7396633-B2 | Damascene process; forming connectors; exposure; development; using acid generator, quencher and buffer | NEC ELECTRONICS CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20070141513-A1 | Positive photosensitive composition | FUJI PHOTO FILM CO., LTD. | 2007-06-21 | — | — | US | disclosed |
| US-7192681-B2 | Positive photosensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-20040259029-A1 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-0054513-B1 | PROCESS FOR THE PRODUCTION OF PHOTOGRAPHIC COLOUR IMAGES ACCORDING TO THE SILVER DYE BLEACHING PROCESS, AND PHOTOGRAPHIC MATERIAL USED IN THIS PROCESS | CIBA-GEIGY AG (CH) | 1985-10-30 | — | — | EP | disclosed |
| US-4465763-A | OIL SOLUBLE TRIAZINE COMPOUND AND A PHENYL AMINE COUPLER | CIBA GEIGY AG (CH) | 1984-08-14 | — | — | US | disclosed |
| US-4404273-A | Process for the production of photographic color images by the silver dye bleach process | CIBA-GEIGY AG (CH) | 1983-09-13 | — | — | US | disclosed |
| EP-0054513-A1 | Process for the production of photographic colour images according to the silver dye bleaching process, and photographic material used in this process | CIBA-GEIGY AG (CH) | 1982-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336892-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP2 | CA12 2856/4885CA1 3458/4885CA2 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.